These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sequential disseminated aspergillosis and pulmonary tuberculosis in a patient treated by idelalisib for chronic lymphocytic leukemia. Lafon-Desmurs B; Monsel G; Leblond V; Papo M; Caumes E; Fekkar A; Jaureguiberry S Med Mal Infect; 2017 Jun; 47(4):293-296. PubMed ID: 27818019 [No Abstract] [Full Text] [Related]
5. Idelalisib in Waldenström macroglobulinemia: high incidence of hepatotoxicity. Castillo JJ; Gustine JN; Meid K; Dubeau T; Yang G; Xu L; Hunter ZR; Treon SP Leuk Lymphoma; 2017 Apr; 58(4):1002-1004. PubMed ID: 27562445 [No Abstract] [Full Text] [Related]
6. Management of adverse events associated with idelalisib treatment: expert panel opinion. Coutré SE; Barrientos JC; Brown JR; de Vos S; Furman RR; Keating MJ; Li D; O'Brien SM; Pagel JM; Poleski MH; Sharman JP; Yao NS; Zelenetz AD Leuk Lymphoma; 2015; 56(10):2779-86. PubMed ID: 25726955 [TBL] [Abstract][Full Text] [Related]
7. Idelalisib for chronic lymphocytic leukemia. Brown JR Clin Adv Hematol Oncol; 2014 Dec; 12(12):846-8. PubMed ID: 25674842 [No Abstract] [Full Text] [Related]
8. Idelalisib-induced colitis and skin eruption mimicking graft-versus-host disease. Hammami MB; Al-Taee A; Meeks M; Fesler M; Hurley MY; Cao D; Lai JP Clin J Gastroenterol; 2017 Apr; 10(2):142-146. PubMed ID: 28025783 [TBL] [Abstract][Full Text] [Related]
9. Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper. Cuneo A; Barosi G; Danesi R; Fagiuoli S; Ghia P; Marzano A; Montillo M; Poletti V; Viale P; Zinzani PL Hematol Oncol; 2019 Feb; 37(1):3-14. PubMed ID: 30187496 [TBL] [Abstract][Full Text] [Related]
13. [Grave diarrhea associated with idelalisib administration]. Suárez Del Olmo D; Corregidor Luna L; Hidalgo Correas FJ; García Benayas E; García Díaz B Farm Hosp; 2016 May; 40(3):227-9. PubMed ID: 27145392 [No Abstract] [Full Text] [Related]
14. Multiple mucosal ulcerations caused by idelalisib. Galeone M; Antiga E Int J Dermatol; 2017 Sep; 56(9):e180-e181. PubMed ID: 28244069 [No Abstract] [Full Text] [Related]
15. Management of psoriasis-like rash associated with idelalisib monotherapy in a patient with refractory follicular lymphoma: a case report. Machan S; Plaza C; Pérez-González Y; Rodriguez-Pinilla M; Requena L; Cordoba R J Med Case Rep; 2020 Feb; 14(1):35. PubMed ID: 32093776 [TBL] [Abstract][Full Text] [Related]
16. Idelalisib-induced pneumonitis. Gupta A; Li HC BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27485880 [No Abstract] [Full Text] [Related]
17. Colitis due to idelalisib in a patient with follicular lymphoma. Canelo-Vilaseca M; Ribera Santasusana JM; Sancho Cia JM Med Clin (Barc); 2022 Jul; 159(2):106. PubMed ID: 35525678 [No Abstract] [Full Text] [Related]